Skip Navigation

European Heart Journal 1999 20(3):196-202; doi:10.1053/euhj.1998.1311
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tomai, F.
Right arrow Articles by Gioffrè, P.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomai, F.
Right arrow Articles by Gioffrè, P.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Effects of KATPchannel blockade by glibenclamide on the warm-up phenomenon

F. Tomaia,f1, A. Danesib, A.S. Ghinia, F. Creac, M. Perinoa, A. Gaspardonea, G. Ruggerib, L. Chiarielloa and P.A. Gioffrèa

a Divisione di Cardiochirurgia, Università di Roma Tor Vergata, European Hospital, Rome, Italy
b Divisione di Cardiologia, Ospedale S. Giuseppe Albano, Rome, Italy
c Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Rome, Italy

accepted September 2, 1998

Abstract

Aims

The increased tolerance to myocardial ischaemia observed during the second of two sequential exercise tests, i.e. the warm-up phenomenon, has been proposed as a clinical model of ischaemic preconditioning. As ATP-sensitive K+channels appear to be a mediator of ischaemic preconditioning in both experimental and clinical studies, the aim of this study was to investigate the role of KATPchannels in the warm-up phenomenon.

Methods and Results

Twenty-six patients with coronary artery disease were randomized to receive 10mg oral glibenclamide, a selective ATP-sensitive K+channel blocker, or placebo. Sixty minutes after glibenclamide or placebo administration, patients were given an infusion of 10% dextrose (8ml.min–1) to correct glucose plasma levels or, respectively, an infusion of saline at the same infusion rate. Thirty minutes after the beginning of the infusions, both patient groups underwent two consecutive treadmill exercise tests, with a recovery period of 15min to re-establish baseline conditions. Before exercise tests, blood glucose levels were similar in placebo and glibenclamide groups (96±10 vs 105±22mg.100ml–1,P=ns). After placebo administration, rate-pressure product at 1·5mm ST-segment depression significantly increased during the second exercise test compared to the first (220±41 vs 186±29 beats.min–1.mmHg.102,P<0·01), but it did not change after glibenclamide (191±34 vs 187±42 beats.min–1.mmHg.102,P=ns), with a significant drug-test interaction (P=0·0091, at two-way ANOVA).

Conclusions

Glibenclamide, at a dose previously shown to abolish ischaemic preconditioning during coronary angioplasty, prevents the increase of ischaemic threshold observed during the second of two sequential exercise tests. These findings confirm that ischaemic preconditioning plays a key role in the warm-up phenomenon and that in this setting is, at least partially, mediated by activation of ATP-sensitive K+channels.

Key Words: Glibenclamide • ischaemic preconditioning • KATPchannel • warm-up phenomenon

f1 Correspondence:Dr Fabrizio Tomai, Divisione di Cardiochirurgia, Università di Roma Tor Vergata, European Hospital, via Portuense 700, 00149 Rome, Italy.

Marber, MSYellon, DM


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
British Journal of Diabetes & Vascular DiseaseHome page
P. Valensi and G. Slama
Review: Sulphonylureas and cardiovascular risk: facts and controversies
The British Journal of Diabetes & Vascular Disease, July 1, 2006; 6(4): 159 - 165.
[Abstract] [PDF]


Home page
Eur Heart JHome page
R. J. Edwards, S. R. Redwood, P. D. Lambiase, and M. S. Marber
The effect of an angiotensin-converting enzyme inhibitor and a K+ATP channel opener on warm up angina
Eur. Heart J., March 2, 2005; 26(6): 598 - 606.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. A Kloner, M. T Speakman, and K. Przyklenk
Ischemic preconditioning: a plea for rationally targeted clinical trials
Cardiovasc Res, August 15, 2002; 55(3): 526 - 533.
[Full Text] [PDF]


Home page
HeartHome page
F Tomai
Warm up phenomenon and preconditioning in clinical practice
Heart, February 1, 2002; 87(2): 99 - 100.
[Full Text] [PDF]


Home page
HeartHome page
A D Kelion, T P Webb, M A Gardner, O J M Ormerod, G L Shepherd, and A P Banning
Does a selective adenosine A1 receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease?
Heart, February 1, 2002; 87(2): 115 - 120.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. F. del Valle, E. C. Lascano, J. A. Negroni, and A. J. Crottogini
Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep
Cardiovasc Res, June 1, 2001; 50(3): 474 - 485.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Yellon and A. Dana
The Preconditioning Phenomenon : A Tool for the Scientist or a Clinical Reality?
Circ. Res., September 29, 2000; 87(7): 543 - 550.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.